A phase III study of combination therapy with everolimus plus lanreotide versus everolimus monotherapy for unresectable or recurrent gastroenteropancreatic neuroendocrine tumor (JCOG1901, STARTER-NET) ...
Carcinoid tumors are typically cancerous. These slow-growing tumors are often found in the gut or the lungs years after they first develop. They can spread to other parts of the body. Carcinoid tumors ...
Carcinoid tumors are often described as “quiet cancers.” They grow slowly, may appear in unexpected parts of the body, and ...
Carcinoid syndrome affects certain people who have neuroendocrine tumors (NETs). Carcinoid syndrome can occur when an NET secretes hormones into the bloodstream. This can cause symptoms such as facial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback